US CDC tightens security after gunman attacks Atlanta headquarters
The union representing workers at the Centers for Disease Control and Prevention said the violence 'compounds months of mistreatment, neglect, and vilification that CDC staff have endured,' citing reports that the gunman blamed the COVID-19 vaccine for making him depressed and suicidal.
Since being named Health and Human Services Secretary earlier this year, Robert F. Kennedy Jr. has targeted vaccine policy, and in May withdrew a federal recommendation for COVID shots for pregnant women and healthy children.
Kennedy toured the CDC site on Monday, where agency security pointed out shattered windows across multiple buildings, including the main guard booth, HHS said in a statement. He also visited the DeKalb County Police Department and met privately with the widow of Officer David Rose, who gave his life in the line of duty.
'No one should face violence while working to protect the health of others,' Kennedy Jr. said in a post on X on Saturday.
HHS said it continues to support CDC personnel and additional safety and security measures are being put in place ahead of their return to the office.
A source briefed on the matter told Reuters that 189 rounds of gunfire had hit the CDC buildings during the attack, 85 windows were broken and over 100 doors destroyed, among other damage.
Both local and federal law enforcement are 'conducting intensive monitoring of all potential threats to CDC and its staff,' the agency's acting Chief Operating Officer Christa Capozzola said in an email to staff over the weekend that was seen by Reuters.
She said work was under way to clean up and repair extensive damage to the CDC's campus by the shooter who, according to the investigation so far, acted alone.
An 'all-staff' meeting on Tuesday will become a virtual-only event, CDC Director Susan Monarez said in a separate email seen by Reuters. She said teams were working to determine 'our workplace posture' moving forward.
The agency's safety division asked employees to remove CDC-identifying decals from their vehicles, an email seen by Reuters showed.
The Atlanta Police Department referred calls to the Georgia Bureau of Investigation, which did not have an immediate comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
5 hours ago
- Al Arabiya
Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH
Novo Nordisk said on Friday the US Food and Drug Administration has granted accelerated approval for its weight-loss drug Wegovy to treat a serious liver condition called metabolic dysfunction-associated steatohepatitis, strengthening its presence in the metabolic disease market. The approval makes Wegovy the first GLP-1 class therapy cleared for MASH, a progressive liver condition that affects around 5 percent of adults in the United States, according to the American Liver Foundation. 'There really (have) not been good treatments in this space. We're only the second FDA-approved treatment for MASH, and we really need better medications that have better overall benefit-risk profiles, that really can also prevent the progression of the disease,' Jason Brett, principal US medical head at Novo Nordisk, said in an interview with Reuters. So far, the only available FDA-approved treatment for MASH is the Madrigal Pharmaceuticals drug Rezdiffra, which was approved in 2024. The FDA's decision was based on part one of an ongoing two-part study that showed Wegovy helped improve the organ's condition in more patients with MASH and liver scarring, compared to a placebo. Novo Nordisk said the drug is now available in the United States for adults with MASH and moderate to advanced liver scarring, and is to be used alongside proper diet and exercise. 'MASH patients need access to treatments - and that really can help them, especially early - to prevent it from progressing,' Brett said. 'We're doing as much as we can to work and partner with the payer community around enhancing access and reimbursement.' Brett did not provide any pricing details. Based on results from part one of the trial, Novo has applied this year for approval in Europe and Japan. Further results from part two of the trial are expected in 2029. Rival Eli Lilly's tirzepatide - the active ingredient in its popular diabetes drug Mounjaro and weight-loss treatment Zepbound - previously helped up to 74 percent of patients achieve absence of MASH with no worsening of scarring in a mid-stage trial. Accelerated approvals allow the FDA to move therapies that target serious and life-threatening conditions to the market more quickly. However, such approvals have been criticized because some drugs have later been proven to be ineffective.
Arab News
a day ago
- Arab News
How Saudi Arabia is tackling soil pollution to protect the environment and human health
RIYADH: Soil pollution underpins some of the most urgent threats to human health, food security and climate resilience. From oil spills and mining to poor waste management and overuse of agrochemicals, contamination is eroding ecosystems and livelihoods worldwide. Environmental agencies have long warned about the consequences — biodiversity loss, degraded farmland, polluted groundwater and higher disease risks — and are intensifying efforts to turn awareness into action. 'We depend, and will continue to depend, on the ecosystem services provided by soils,' Abdelkader Bensada, a soil expert at the UN Environment Programme, said about the risks of soil pollution on food security and health. The warning is stark: When soils fail, crops falter, water quality declines and public health inevitably suffers. According to the European Environment Agency, more than 500,000 premature deaths are linked to soil pollution globally. UNEP estimates that almost 40 percent of the global population — more than 3 billion people — are affected by soil degradation. Behind those figures lies a wide array of contaminants. Heavy metals, hydrocarbons and industrial and agricultural chemicals can accumulate in soil, reduce fertility, infiltrate aquifers and ultimately enter the food chain. Recognizing the scale of the problem, the Food and Agriculture Organization of the UN and its Global Soil Partnership convened the Global Symposium on Soil Pollution in 2018, alongside the World Health Organization, the Secretariat of the Basel, Rotterdam and Stockholm Convention, and UNEP. The aim was to bring together science and policy to assess the status, causes, impacts and solutions — and to move the issue from technical papers into concrete action plans. Science is clear about where much of the pollution originates. In terrestrial ecosystems, soils are the dominant sink for heavy metal contamination. An FAO/UN assessment in 2018 highlighted fundamental sources, including chemicals associated with industrial byproducts, domestic and livestock uses, municipal wastes, agrochemicals and oil-derived products. Contaminants can enter soils accidentally — as with oil spills — or intentionally through human activity, including the application of fertilizers and pesticides and the use of untreated wastewater for irrigation, as outlined by UNEP. Urban expansion and desertification compound these pressures, sealing soils under concrete, stripping vegetation and accelerating erosion. Saudi Arabia, with its expanding industrial base and rapid urban development, has been mapping and managing these risks more aggressively in recent years. Heavy metals such as lead, mercury and arsenic have been detected in soils across industrial regions including Yanbu, Riyadh, Jubail and Al-Ahsa. These materials can impair plant growth by triggering oxidative stress and disrupting enzyme activity. More worrying still, contaminants can move through the food chain, posing hazards to human health. A growing body of local research is helping to target interventions. In 2023, Khaled Al-Kahtany of King Saud University's Department of Geology and Geophysics published 'Ecological risk assessment of heavy metals contamination in agricultural soil from Al-Majma'ah, central Saudi Arabia.' The study identified increased levels of potentially toxic elements, including arsenic, mercury and uranium. Reassuringly, most were below global risk thresholds. Even so, the findings underscore the need for early interventions that prevent hotspots from becoming health emergencies. Policy has moved in tandem with science. Guided by Vision 2030, Saudi Arabia is weaving environmental protection into its economic transformation. A key step came in 2020 with the adoption of the Executive Regulation for Soil Pollution Prevention and Remediation, issued by the Ministry of Environment, Water and Agriculture. The regulation sets protection standards, remediation requirements, site monitoring protocols, and penalties for violations — giving regulators and industry a clear rulebook for preventing and cleaning up contamination. Institutions have been retooled to enforce those rules. The establishment of the National Center for Environmental Compliance signaled a shift toward continuous monitoring and rapid response. As of May this year, 16 mobilization exercises have been carried out, with NCEC overseeing operations implemented by Marine Operations for Environmental Services (SAIL), which operates the largest environmental emergency fleet in the Middle East. These exercises pair advanced satellite remote sensing with ship-based pollution control equipment and mechanisms — an important capability in a country with a vast coastline, busy ports and critical marine ecosystems. The operational emphasis is twofold — prevent pollution at source through standards, audits and permits, and be ready to contain incidents quickly when they occur. Remote sensing helps pinpoint anomalies over wide areas. Ground teams then prioritize inspections, deploy containment booms, or initiate soil and water sampling. In industrial zones, authorities are tightening requirements for hazardous waste tracking, storage infrastructure and emergency preparedness. In agriculture, the focus includes better guidance on fertilizer and pesticide use, promotion of treated wastewater standards and incentives for soil-health practices that build organic matter and reduce runoff. Saudi officials also stress that remediation is not the end of the story. Sustainable land management — from re-vegetation and erosion control to improved drainage — reduces the chance of re-contamination and strengthens climate resilience. The broader push aligns with global efforts catalyzed by GSOP18: Treat soil as natural capital that underwrites food systems, not as an infinite sink for waste. The public message is growing sharper as well. Soil pollution has never been so critical and threatening. The planet nowadays seems to be suffering a significant number of environmental issues, making international cooperation all the more urgent. That urgency was echoed by UNEP chief Inger Andersen on Zero Waste Day last year. 'Metal, minerals, food, water, now we know that such resources are essential, but the truth is that, day in and day out, we waste them. Our planet cannot keep endlessly giving up resources and receiving pollution in return,' he said. 'Remember that nature doesn't waste. And nor should we.'
Al Arabiya
2 days ago
- Al Arabiya
Whoop refuses to disable blood pressure tool despite FDA warning
Whoop Inc., the maker of screen-less fitness bands, said it will not disable its blood-pressure tracking tool despite a request from the US Food and Drug Administration. The FDA last month sent a warning letter to Whoop stating that the company's Blood Pressure Insights feature, or BPI, which both measures blood pressure and provides related feedback, means that the Whoop is operating as a medical device. The new Whoop MG — short for medical grade — doesn't have such certification for blood pressure tracking despite intending to 'help with the diagnosis, cure or treatment of a disease,' according to the government agency. The band launched in May with the feature as a central addition. Whoop pushed back on the FDA's warning in a letter to the agency dated Aug. 4. 'We believe it is not within the FDA's authority to regulate the product. We therefore do not intend to remove the app,' the company wrote. 'We will continue to offer the wellness feature to consumers.' It added in a statement that it has 'requested a meeting with the FDA and hopes to have a constructive dialogue with agency officials.' On Thursday an FDA spokesperson said the agency 'has not authorized BPI for any use, including for the measurement or estimation of a user's blood pressure,' adding that 'patient safety is the FDA's highest priority.' FDA Versus Tech The FDA has clashed periodically over the last dozen years with technology companies whose devices the agency believes need regulation because they constitute medical advice. Still, Whoop's defiant reaction is rare. While regulators have struggled to define exactly when the line from wellness to medical advice is crossed, tech firms have often taken offending products off the market and sought FDA clearance or tweaked their product to comply. Meanwhile, consumer hardware makers have been adding more sophisticated health tracking tools to their fitness bands and smartwatches, blurring the lines between a wearable gadget and medical device. While the FDA can impose injunctions and fines on companies that fail to comply with violations raised in warning letters, it's rare that it follows through. The agency initially told Whoop that it should take 'prompt action' to address any violations or face potential regulatory action, including seizure, injunction and civil monetary penalties. The FDA also told Whoop it could go through the normal device approval process, something that Whoop doesn't want to do given the long amount of time that could take. Whoop said in its response that the feature is labeled for wellness purposes, not for diagnosing or treating medical conditions like hypertension. Whoop also said that repeated disclaimers are provided during the sign-up process. It characterized the issue as a 'misinterpretation' by the FDA, saying the agency views blood pressure estimation as a medical tool. The 'FDA's assertions fail to account for the substantial and growing body of scientific evidence supporting non-medical uses of blood pressure as well as the actual use of blood pressure information by the feature,' the company said in its response, which was provided to Bloomberg News. The Blood Pressure Insights feature lets users get a daily estimate of their blood pressure range so they can better understand the impact on overall health and athletic performance. The tool is available only to subscribers of the $359-a-year Whoop Life plan. The feature requires an initial calibration with a standard blood pressure cuff. Whoop Chief Executive Officer Will Ahmed previously called the FDA's letter 'misguided' on social media. The FDA said the product does not fall under the general wellness device policy because blood pressure it is not a low-risk use case. 'An erroneously low or high blood pressure reading can have significant consequences for the user,' it said in its July letter to the fitness startup. During an interview with Bloomberg TV on Thursday, Ahmed said he believes the company will be on the 'right side of history' and fighting for Americans' access to health data is the 'right thing to do.' 'Ultimately, innovation needs to be built to thrive in the United States,' he said. 'We're one of the first wearables that can measure blood pressure accurately on the wrist. That's a big deal. We want to make sure that there are policies that are consistent here in the US that really allow companies to innovate and to operate.' Other companies such as Garmin Ltd. offer FDA-cleared blood pressure reading tools. It's a feature also available on smartwatches from Samsung Electronics Co. Health and Human Services Secretary Robert F. Kennedy Jr. has promoted the use of wearable fitness devices. In an appearance before Congress in June, he said his vision is for every American to be using a wearable device within four years. Whoop CEO Ahmed was pictured meeting with Kennedy and other health tech companies in May.
